Diagnosis of Quinolone Hypersensitivity: An EAACI Position Paper
Allergy · 2025-11 · 80 (11) · 2988-3011
DOI: 10.1111/all.70037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, online erschienen am 10.09.2025. Verfasst von Aslı Gelincik und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Allergic Diseases, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Hypersensitivity, Quinolones. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 113 Literaturangaben.
Abstract (Originalsprache)
Hypersensitivity reactions to quinolones (QHRs) have been increasing in frequency, thus classifying them as the second most frequently implicated class of antibiotics in hypersensitivity reactions (HRs). It is noteworthy that quinolones (Qs) have been observed to predominantly trigger immediate hypersensitivity reactions (IHRs). These reactions are categorized as either IgE‐mediated or non‐IgE‐mediated, attributable to the off‐target occupation of the recently described receptor, Mas‐related G‐protein coupled receptor member X2 (MRGPRX2), on effector cells. The increasing trend of HRs underscores the necessity for enhanced diagnostic and management strategies. The present position paper aims to shed light on the key mechanisms involved in immediate and non‐immediate QHRs. The clinical spectrum of these reactions is discussed, as well as the utility of skin tests, in vitro diagnostic tests, and drug provocation tests in diagnosis. A further focal point of this study is the analysis of cross‐reactivity between various Qs. The paper concludes with the presentation of diagnostic algorithms for both immediate and non‐immediate QHRs. The paper's findings aid clinical practice for QHRs and address unmet needs, which should stimulate more in‐depth investigations into the mechanisms and clinical practice of QHRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Immunology and Allergic Diseases, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul, Türkiye.
- Department of Dermatology and Allergy Biederstein, Faculty of Medicine and Health, TUM University Hospital, Munich, Germany.
- Department of Immunology and Allergy (Retired), Ankara University School of Medicine and Private Practise, Ankara, Türkiye.
- Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
- Allergy Research Group, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Málaga, Spain.
- RICORS de Enfermedades Inflamatorias, Instituto de Salud Carlos III, Madrid, Spain.
ORCID-Profile: Aslı Gelincik, Knut Brockow, Gülfem E Çelik, Semra Demir, Inmaculada Doña Diaz, Didier G Ebo, Cristobalina Mayorga, Marina Labella, Vito Sabato, María José Torres Jaén
Zitieren
APA
Gelincik, A., Brockow, K., Çelik, G. E., Demir, S., Doña Diaz, I., Ebo, D. G., Mayorga, C., Labella, M., Sabato, V., & Jaén, M. J. T. (2025). Diagnosis of Quinolone Hypersensitivity: An EAACI Position Paper. Allergy, 80(11), 2988-3011. https://doi.org/10.1111/all.70037
Vancouver
Gelincik A, Brockow K, Çelik GE, Demir S, Doña Diaz I, Ebo DG, et al. Diagnosis of Quinolone Hypersensitivity: An EAACI Position Paper. Allergy. 2025;80(11):2988-3011. doi:10.1111/all.70037
BibTeX
@article{Gelincik2025,
author = {Gelincik, Aslı and Brockow, Knut and Çelik, Gülfem E and Demir, Semra and Doña Diaz, Inmaculada and Ebo, Didier G and Mayorga, Cristobalina and Labella, Marina and Sabato, Vito and Jaén, María José Torres},
title = {Diagnosis of Quinolone Hypersensitivity: An EAACI Position Paper},
journal = {Allergy},
year = {2025},
volume = {80},
number = {11},
pages = {2988--3011},
doi = {10.1111/all.70037}
}
EUVIMED